SARS-CoV-2 genomics as a springboard for future disease mitigation in LMICs.

Belman, Sophie; Saha, Senjuti; Beale, Mathew A

Belman, Sophie; Saha, Senjuti; Beale, Mathew A.

Belman S; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Saha S; Child Health Research Foundation, Dhaka, Bangladesh.
Beale MA; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. mathew.beale@sanger.ac.uk.

Nat Rev Microbiol ; 20(1): 3, 2022 01.

Article in English | MEDLINE | ID: covidwho-1526084

Subject(s)

COVID-19/epidemiology; Genome, Viral; Genomics/economics; Nanopore Sequencing/economics; SARS-CoV-2/genetics; Africa/epidemiology; Bangladesh/epidemiology; COVID-19/diagnosis; COVID-19/economics; COVID-19/transmission; Developing Countries/economics; Epidemiological Monitoring; Genomics/instrumentation; Genomics/methods; Humans; Nanopore Sequencing/instrumentation; Nanopore Sequencing/methods; Phylogeny; SARS-CoV-2/classification; SARS-CoV-2/isolation & purification; SARS-CoV-2/pathogenicity

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Genome, Viral / Genomics / Nanopore Sequencing / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Randomized controlled trials Limits: Humans Country/Region as subject: Africa / Asia Language: English Journal: Nat Rev Microbiol Journal subject: Microbiology Year: 2022 Document Type: Article Affiliation country: S41579-021-00664-y

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google